{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:17:10Z","timestamp":1789474630565,"version":"build-2803163510"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>The objectives of this study were to determine alcohol consumption after administration of (<jats:italic toggle=\"yes\">R<\/jats:italic>)(-)-2,5-dimethoxy-4-iodoamphetamine (DOI) or naltrexone in Long\u2013Evans rats, and to assess the effectiveness of these treatments based on individual differences in alcohol consumption. Adult male Long\u2013Evans rats (<jats:italic toggle=\"yes\">N<\/jats:italic> = 16) were given opportunities to orally self-administer a 20% (v\/v) ethanol (EtOH) solution using an intermittent access, two-bottle (vs. tap water) choice procedure in their home cages. EtOH consumption and preference, total fluid consumption and food intake were measured. Last, we assessed the effects of naltrexone (1 mg\/kg; subcutaneous) and (<jats:italic toggle=\"yes\">R<\/jats:italic>)(-)-DOI (0.1\u20131 mg\/kg; subcutaneous) on EtOH intake and preference using a quartile analysis. Rats showed stable EtOH (20%) intake and preference after 15 EtOH access sessions. Naltrexone produced a transient decrease in EtOH intake, but an inconsistent effect on EtOH preference, whereas DOI dose-dependently reduced EtOH intake and preference for at least 24 h. Subsequent quartile analyses revealed that rats with the highest EtOH intake during the first 60 min of access to EtOH showed greater reductions in EtOH intake and preference after DOI treatment. This is the first report to show that DOI-elicited reductions in EtOH intake and preference in rats depend on baseline EtOH intake, perhaps supporting a \u2018baseline dependency\u2019 hypothesis of effectiveness with phenethylamine psychedelics on EtOH consumption. If so, individuals with greater potential to develop severe AUDs may be particularly responsive to the positive motivational changes produced by treatment with psychedelics that target the 5-HT2 receptor family.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000628","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T21:18:50Z","timestamp":1614374330000},"page":"382-391","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long\u2013Evans rats"],"prefix":"10.1097","volume":"32","author":[{"given":"Michael D.","family":"Berquist","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Fantegrossi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3389\/fphar.2018.00994","article-title":"LSD administered as a single dose reduces alcohol consumption in C57BL\/6J mice.","volume":"9","author":"Alper","year":"2018","journal-title":"Front Pharmacol"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"Suppl 1","key":"R3-20250614","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000284626","article-title":"Buspirone in the treatment of alcoholic patients.","volume":"22","author":"Bruno","year":"1989","journal-title":"Psychopathology"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.alcohol.2008.12.001","article-title":"Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor.","volume":"43","author":"Carnicella","year":"2009","journal-title":"Alcohol"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1530-0277.2007.00536.x","article-title":"Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up.","volume":"31","author":"Dawson","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1126\/science.563103","article-title":"Rate-dependency hypothesis.","volume":"198","author":"Dews","year":"1977","journal-title":"Science"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1111\/bph.12707","article-title":"Drug effects on multiple and concurrent schedules of ethanol- and food-maintained behaviour: context-dependent selectivity.","volume":"171","author":"Ginsburg","year":"2014","journal-title":"Br J Pharmacol"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/ajp.152.3.391","article-title":"Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.","volume":"152","author":"Kranzler","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials.","volume":"26","author":"Krebs","year":"2012","journal-title":"J Psychopharmacol"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.","volume":"28","author":"Johnson","year":"2014","journal-title":"J Psychopharmacol"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"392","DOI":"10.9740\/mhc.2019.11.392","article-title":"Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans.","volume":"9","author":"Leighty","year":"2019","journal-title":"Ment Health Clin"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(99)00125-9","article-title":"5-HT receptor ligands differentially affect operant oral self-administration of ethanol in the rat.","volume":"370","author":"Maurel","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0091-3057(98)00115-4","article-title":"5-HT2A and 5-HT2C\/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats.","volume":"62","author":"Maurel","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics.","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol Rev"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s00213-019-05328-7","article-title":"Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.","volume":"236","author":"Oppong-Damoah","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00004714-200104000-00005","article-title":"Double-blind clinical trial of sertraline treatment for alcohol dependence.","volume":"21","author":"Pettinati","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/B978-0-12-385506-0.00010-7","article-title":"Role of the serotonergic system in alcohol dependence: from animal models to clinics.","volume":"98","author":"Sari","year":"2011","journal-title":"Prog Mol Biol Transl Sci"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1530-0277.2008.00753.x","article-title":"Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats.","volume":"32","author":"Simms","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/npp.2010.15","article-title":"Long-Evans rats acquire operant self-administration of 20% ethanol without sucrose fading.","volume":"35","author":"Simms","year":"2010","journal-title":"Neuropsychopharmacology"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:04:17Z","timestamp":1749938657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000628","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}